Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02215369 · ClinicalTrials.gov registry record · NA
SeCure Endovenous Laser Treatment Study
A NA study, sponsored by Angiodynamics.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT02215369 is a NA study that has completed, run by Angiodynamics. The registered enrollment target is 112 participants.
The verdict
NCT02215369, a NA study, has completed, sponsored by Angiodynamics.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The VenaCure EVLT 400 µm Fiber Kit is currently marketed for the treatment of varicose veins. AngioDynamics, Inc., the company that manufacturers the VenaCure device, is sponsoring this study to assess the safety and effectiveness of the VenaCure EndoVenous Laser Treatment (EVLT) 400 µm Fiber Kit for treatment of incompetent perforator veins (IPVs). The VenaCure EVLT 400 µm Fiber Kit has not been previously studied by AngioDynamics for the ablation of IPVs.
Interventions
- DEVICE VenaCure EVLT 400 µm fiber Procedure Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-01-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02215369
The ClinicalTrials.gov registry entry for NCT02215369 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Angiodynamics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VenaCure EVLT 400 µm fiber Procedure Kit is the first listed.
NCT02215369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02215369 about?
NCT02215369 is a clinical study titled "SeCure Endovenous Laser Treatment Study". The VenaCure EVLT 400 µm Fiber Kit is currently marketed for the treatment of varicose veins. AngioDynamics, Inc., the company that manufacturers the VenaCure device, is sponsoring this study to assess the safety and effectiveness of the VenaCure EndoVenous Laser Treatment (EVLT) 400 µm Fiber Kit fo...
What is the current status of trial NCT02215369?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2015-01. Estimated completion is 2019-01-14.
What interventions are being tested in trial NCT02215369?
The interventions under investigation include: VenaCure EVLT 400 µm fiber Procedure Kit (DEVICE).
Who is sponsoring clinical trial NCT02215369?
This trial is sponsored by Angiodynamics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.